- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05993793
Use of Fototherapy in the Treatment of Fissure in Ano
August 7, 2023 updated by: Centro de Atenção ao Assoalho Pélvico
Use of Fototherapy in the Treatment of Fissura in Ano
The eligible population consisted of individuals with anal fissure awaiting surgical intervention.
Individuals aged 18 years or older were included, diagnosed with anal fissure and who voluntarily agreed to participate in the research.
Those who had some pelvic inflammation and who had already undergone a surgical procedure and had recurrence were excluded from the studyThe selected individuals underwent a standardized anamnesis of the service, answered questionnaires on symptoms of intestinal constipation (Rome IV Criteria and the Bristol Scale), underwent a physical evaluation by a trained professional, and then began the application of the research protocol.
The Antares brand Laser device was used for 3 sessions with an interval of 24 hours.
The Visual Analogue Scale (VAS) was used before starting treatment, after the first and second sessions, and 1 week after the third session.
In addition, at the end of the treatment, the closure, or not, of the lesion was verified, and the questionnaires performed prior to phototherapy were reapplied.
The VAS assesses the patient's level of pain, which can be divided into mild pain (1-2), moderate pain (3-7), and severe pain (8-10).
The Bristol Scale is based on the identification of the patient's consistency of stools, while types 1-2 correspond to constipation, 3-4 indicate normal intestinal rhythm, 5 indicate lack of fiber, and 6-7 correspond to diarrhea.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BA
-
Salvador, BA, Brazil, 41825-000
- Instituto Patrícia Lordelo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- individuals with the diagnosis of anal fissure that accepted to participate as volunteers in the clinical trial
Exclusion Criteria:
- individuals with pelvic inflammation
- individuals who have been through surgical procedures
- individuals who have relapse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fototherapy
|
The Antares brand Laser device was used for 3 sessions with an interval of 24 hours.
The Visual Analogue Scale (VAS) was used before starting treatment, after the first and second sessions, and 1 week after the third session.
In addition, at the end of the treatment, the closure, or not, of the lesion was verified, and the questionnaires performed prior to phototherapy were reapplied.
The VAS assesses the patient's level of pain, which can be divided into mild pain (1-2), moderate pain (3-7), and severe pain (8-10).
The Bristol Scale is based on the identification of the patient's consistency of stools, while types 1-2 correspond to constipation, 3-4 indicate normal intestinal rhythm, 5 indicate lack of fiber, and 6-7 correspond to diarrhea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complete closure of the fissure
Time Frame: 15 days
|
It is estimated that the fototherapy will close completely the fissure in patients with fissure in ano.
|
15 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
August 30, 2022
Study Completion (Actual)
December 20, 2022
Study Registration Dates
First Submitted
August 7, 2023
First Submitted That Met QC Criteria
August 7, 2023
First Posted (Actual)
August 15, 2023
Study Record Updates
Last Update Posted (Actual)
August 15, 2023
Last Update Submitted That Met QC Criteria
August 7, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 53623621.0.0000.5544
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fissure in Ano
-
IpsenCompletedAnal FissureCzechia, Poland, Romania, Tunisia
-
Onze Lieve Vrouwe GasthuisCompleted
-
Dieter HahnloserCompleted
-
Biolab Sanus FarmaceuticaWithdrawn
-
Mansoura UniversityUnknown
-
Bispebjerg HospitalSacomedTerminated
-
Region SkaneCompleted
-
S.L.A. Pharma AGCompletedChronic Anal FissureUnited Kingdom, Spain, Bulgaria, Germany, Lithuania, Romania
-
State Scientific Centre of Coloproctology, Russian...Recruiting
-
Istanbul Medipol University HospitalCompletedAnal Fissure ChronicTurkey